ClinicalTrialsFinder

Sickle Cell Disease, Hemolytic Anemia Clinical Trials in Bethesda, Maryland

1 recruitingBethesda, Maryland

Showing 1–1 of 1 trials

Recruiting
Phase 1

Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

Sickle Cell Disease, Hemolytic Anemia
National Heart, Lung, and Blood Institute (NHLBI)25 enrolled1 locationNCT07566494